Clinical trial
"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM
NCT00402012
Study timeline
Study start (unknown)2006-11-01Date precision: month
Registry last updated2015-12-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
PioglitazoneDRUG · verified · RxNorm: pioglitazone
Sponsors & collaborators
Pennington Biomedical Research Centerlead sponsor
Takeda Pharmaceuticals North America, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00402012 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.